G1 Therapeutics, Inc. (GTHX)

Last Three Months

26-Jan-24 -- 25-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

24

0

3

+1

0

+2

0

+3

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
22-Mar-24 4:09 PM View:	20-Mar-24 Grant 0	Avagliano Mark Chief Business Officer		G1 Therapeutics, Inc. - GTHX	85% 117.83K to 217.83K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 6:14 PM View:	12-Feb-24 Planned Option Sale ($132.14K)	Malik Rajesh Chief Medical Officer		G1 Therapeutics, Inc. - GTHX	0% 169.94K	0	0	--	--	Show Txns Hide Txns

22-Mar-24 4:08 PM View:	20-Mar-24 Grant 0	Umstead John V. Chief Financial Officer		G1 Therapeutics, Inc. - GTHX	24% 130.44K to 161.4K	0	0	--	--	Show Txns Hide Txns

22-Mar-24 4:10 PM View:	20-Mar-24 Grant 0	Thomas Monica R. General Counsel		G1 Therapeutics, Inc. - GTHX	48% 78.15K to 115.65K	0	0	--	--	Show Txns Hide Txns